Central Nervous System Agents in Medicinal Chemistry
Title:Preface
Volume: 18 Issue: 1
Author(s): Gregory S. Hamilton
Affiliation:
Export Options
About this article
Cite this article as:
Hamilton S. Gregory , Preface, Central Nervous System Agents in Medicinal Chemistry 2018; 18 (1) . https://dx.doi.org/10.2174/187152491801180126155039
DOI https://dx.doi.org/10.2174/187152491801180126155039 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
26
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Association Analysis of the Tryptophan Hydroxylase 2 Gene Polymorphisms in Patients with Methamphetamine Dependence/Psychosis
Current Neuropharmacology Targeting Epithelial-Mesenchymal Transition Phenotype for Gastro-Intestinal Cancer
Current Pharmaceutical Design Current Pathogenesis of Alzheimer’s Disease and Plants Derived Neuroprotective Phytoconstituents: A Comprehensive Review
Current Psychopharmacology Motor and Sensory Dysfunction in Musician's Dystonia
Current Neuropharmacology Current Therapeutic Advances in Patients and Experimental Models of Huntington's Disease
Current Drug Targets Beyond Mitochondria, What Would be the Energy Source of the Cell?
Central Nervous System Agents in Medicinal Chemistry Intravascular Targeting of a New Anticoagulant Heparin Compound
Cardiovascular & Hematological Disorders-Drug Targets Neuropeptides and Other Chemical Mediators, and the Role of Anti-inflammatory Drugs in Primary Headaches
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART II
Current Neuropharmacology Lung Ultrasound in the Management of Acute Decompensated Heart Failure
Current Cardiology Reviews Recent Advances in Pathophysiology of Traumatic Brain Injury
Current Neuropharmacology Heart Failure in Minority Populations - Impediments to Optimal Treatment in Australian Aborigines
Current Cardiology Reviews Role of Neurotrophic Factors in Parkinson's Disease
Current Pharmaceutical Design Sudden Infant Death Syndrome from Epidemiology to Pathophysiology
Current Pediatric Reviews Bupropion HCL and Sleep in Patients with Depression
Current Psychiatry Reviews Maternal Sodium Valproate Exposure Alters Neuroendocrine-Cytokines and Oxido-inflammatory Axes in Neonatal Albino Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Chaperone Therapy: New Molecular Therapy for Protein Misfolding Diseases with Brain Dysfunction
Current Bioinformatics Modern drug delivery systems for targeting the posterior segment of the eye
Current Pharmaceutical Design Review on FIB-Induced Damage in Diamond Materials
Current Nanoscience EDITORIAL (Thematic Issue: Brain Gut Axis-New View)
Current Neuropharmacology